ArthramidVet® is used by veterinarians everyday around the world for the treatment of joint lameness in horses. Multiple published studies from high profile institutions, and treating thousands of equine patients across all equestrian disciplines, show that ArthramidVet® is a safe and effective treatment for osteoarthritis and joint lameness in animals. Explore this page for more information and to access findings from studies of ArthramidVet® 2.5% iPAAG.
Arthramid Vet White Paper
Veterinarians: Get your copy of our 24 page white paper today, covering Treatment of Joint Lameness, Pathophysiology, Manufacturing, Mechanism of Action, Clinical Safety and Putting it into Practice.
Scientific Publications
Lowe J, de Clifford L, Julian A, Koene M. Histologic and cytologic changes in normal equine joints after injection with 2.5% injectable polyacrylamide hydrogel reveal low-level macrophage-driven foreign body response. JAVMA 2024
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. (2021). A double-blinded positive control study comparing the relative efficacy of 2.5% polyacrylamide hydrogel (PAAG) against triamcinolone acetonide (TA) and sodium hyaluronate (HA) in the management of middle carpal joint lameness in racing Thoroughbreds
de Clifford, L.D., Lowe, J.N., McKellar, C.D., Bolwell, C., and David, F. (2019). Use of a 2.5% Cross-Linked Polyacrylamide Hydrogel in the Management of Joint Lameness in a Population of Flat Racing Thoroughbreds: A Pilot Study
Henrikson, M., Overgaard, A., and Bliddal, H. (2017). Initial Estimates of Efficacy of Intra-Articular 2.5% Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis: An Observational Proof-of-Concept Study
Bathe, A.P., Read, R.M., and Briggs, C. (2016). Intra-articular polyacrylamide hydrogel for the treatment of 20 horses with non-responsive osteoarthritis of the interphalangeal joints: a prospective study
Christensen, L., Illigen, K.E., Hansen, M., Sarvaa, R., and Conogham, P.G. (2016). Synovial incorporation of polyacrylamide hydrogel after injection into normal and osteoarthritic animal joints
Tnibar et al (2015). An international multi-centre prospective study on the efficacy of an intraarticular polyacrylamide hydrogel in horses with osteoarthritis: a 24 months follow-up
Tnibar et al (2014). Evaluation of a polyacrylamide hydrogel in the treatment of induced osteoarthritis in a goat model: a randomized controlled pilot study
Janssen, I., Koene, M., and Lischer, C. (2012). Intraarticular application of polyacrylamide hydrogel as a treatment of osteoarthritis in the distal interphalangeal joint: Case series with 12 horses
Testimonials
Dr Kim McKeller
AK & K EQUINE SERVICES
BALLARAT, VICTORIA, AUSTRALIA
I have now been using Arthramid Vet for years treating TB’s ,SB’s and equestrian horses. It’s simply the best treatment we have for arthritis.”
Dr Kim McKeller
AK & K EQUINE SERVICES
BALLARAT, VICTORIA, AUSTRALIA
I have been using Arthramid Vet for more than 5 years treating thoroughbreds, standardbreds and equestrian horses. 90 % of my work is lameness identification and treatment. I have injected over 600 joints with Arthramid Vet and I have experienced no side affects.
I have used all the alternative joint treatments over the last 50 years and consider Arthramid with or without triamcinolone superior to all other treatments. 85 % of my thoroughbred lameness localises to the intercarpal joint. If we are treating early cases before severe bone changes have occurred we will achieve long term reduction of joint inflammation. I have been using it as prophylactic in some stables. If we have major bone changes I add triamcinolone as required. I have used Arthramid Vet in Fetlocks, TMT, Coffin, Pastern and stifle joints.In the gliding joints it is a superb product with spectacular results. In my experience joint pain on flexion is gone in 2 weeks and usually lameness markedly reduced but the maximum result is not achieved for 6 weeks. In summary Arthramid Vet is a very valuable treatment option and is my first port of call for all lamenesses involving non septic joint inflammation
I have now been using Arthramid Vet for years treating TB’s ,SB’s and equestrian horses. It’s simply the best treatment we have for arthritis.”
Dr Stuart Vallance
ADVANTAGE EQUINE VETERINARY PRACTICE
ASCOT VALE, VIC, AUSTRALIA
I have utilised hundreds of doses of 2.5% PAAG gel since 2014, and during this period I have learnt how to maximise its benefit”
Dr Stuart Vallance
ADVANTAGE EQUINE VETERINARY PRACTICE
ASCOT VALE, VIC, AUSTRALIA
I have utilised hundreds of doses of 2.5% PAAG gel since 2014, and during this period I have learnt how to maximise its benefit in my caseload of predominantly Thoroughbred racehorses. In my opinion, it can minimise the use of intra-articular corticosteroids or other joint therapies used in Thoroughbred stables. 2.5% PAAG is not a cortisone and shouldn’t be expected to diminish acute inflammation like corticosteroids do. In my opinion, it appears to have the greatest clinical effect in appropriately diagnosed joints with low-grade performance limiting lameness that are treated early in the horse’s preparation, or if utilised within a preparation given time (approximately 3 weeks) before one would expect to see a marked clinical improvement.
I have utilised hundreds of doses of 2.5% PAAG gel since 2014, and during this period I have learnt how to maximise its benefit”